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ABSTRACT
Streptococcus suis is a Gram-positive bacterium and a zoonotic pathogen residing in the naso-
pharynx or the gastrointestinal tract of pigs with a potential of causing life-threatening invasive
disease. It is endemic in the porcine production industry worldwide, and it is also an emerging
human pathogen. After invasion, the pathogen adapts to cause bacteremia and disseminates to
different organs including the brain. To gain insights in this process, we infected piglets with
a highly virulent strain of S. suis, and bacterial transcriptomes were obtained from blood and
different organs (brain, joints, and heart) when animals had severe clinical symptoms of infection.
Microarrays were used to determine the genome-wide transcriptional profile at different infection
sites and during growth in standard growth medium in vitro. We observed differential expression
of around 30% of the Open Reading Frames (ORFs) and infection-site specific patterns of gene
expression. Genes with major changes in expression were involved in transcriptional regulation,
metabolism, nutrient acquisition, stress defenses, and virulence, amongst others, and results were
confirmed for a subset of selected genes using RT-qPCR. Mutants were generated in two selected
genes, and the encoded proteins, i.e., NADH oxidase and MetQ, were shown to be important
virulence factors in coinfection experiments and in vitro assays. The knowledge derived from this
study regarding S. suis gene expression in vivo and identification of virulence factors is important
for the development of novel diagnostic and therapeutic strategies to control S. suis disease.
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S. suis infection in young pigs causes severe invasive disease
with clinical features such as meningitis, endocarditis,
pneumonia, septicaemia, and arthritis, resulting in
a worldwide problem in the pig production industry. This
pathogen can also infect humans and cause meningitis and
other symptoms associated with septicemia [1,2]. S. suis
infection is associated with occupational exposure to
infected pigs or consumption of raw pork meat [3]. The
number of human cases has increased significantly since
2005, particularly in South-East Asia where S. suis is now
the leading cause of human meningitis [4,5]. In the S. suis
outbreak in China in 2005, disease was more acute and
severe than previously reported, causing toxic shock syn-
drome and high mortality [6,7]. Among the 33 capsular
serotypes described in S. suis, serotype 2 is responsible for
the majority of human and pig infections, and it is also the
most commonly isolated from infected piglets worldwide
[1]. Thus, the increasing emergence of severe infections
and the lack of effective vaccines [8], at least against ser-
otype 2, create an urgent need to prevent disease caused by
this pathogen. Understanding S. suis pathogenesis and
virulence will help to create effective control strategies.
S. suis colonizes the oropharynx and gut of pigs
asymptomatically after birth [9] or through nose-to-
nose contact [10]. In some animals, the pathogen is
able to breach the mucosal barriers and to access and
replicate in blood. Then, bacteria reach the cerebrosp-
inal fluid, joint spaces, and serosal cavities, and rapidly
invade multiple organs including spleen, liver, kidney,
lung, and heart [11]. Piglets are most at risk in the
period post-weaning, possibly as consequence of an
immature immune system and lack of maternal immu-
nity [11]. During colonization, invasion and systemic
disease, S. suis encounters different microenvironments
that differ, for example, in oxygen and carbon dioxide
levels, concentrations of free iron, nutrient availability,
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or host defense factors. To ensure survival, pathogens
are known to rapidly respond to environmental
changes or signals in different host niches [12].
Nutrient availability in a host niche is also considered
a strong driving force in the evolutionary adaptations
of pathogens [13]. In several species of streptococci,
including S. suis, a close link between carbohydrate
metabolism and virulence was indeed demonstrated
[14–16]. In S. suis, for example, carbon catabolite pro-
tein A (CcpA), regulates pathways for uptake and meta-
bolism of carbohydrates as well as several virulence
factors [14,17]. Nevertheless, much remains to be
learned regarding the complete adaptation of S. suis
during infection.
The aim of this study was to determine the whole
genome expression profile of S. suis during infection to
better understand how the bacteria adapt to different
microenvironments in host tissues. Several strategies
have previously been exploited to identify S. suis
genes that are regulated in vivo, including in vivo
expression technology [18], in vivo-induced antigen
technology [19,20], or signature-tagged mutagenesis
[21]. Although these approaches successfully identified
individual genes involved in bacterial pathogenesis, the
interdependence, orchestration and, synchronization of
expression of various genes during infection was not
elucidated, making it difficult to link gene expression to
biological processes. To overcome these limitations, we
used microarrays to study gene expression profiles of
S. suis during an experimental infection of piglets, and
thereby we analyzed characteristic sites of infection. We
also aimed at validating selected genes in an indepen-
dent experimental infection.
Material and methods
Bacterial strains and growth conditions
S. suis strains S735-pCOM1-orf2 [22] and S735-pCOM1
[18], which are both derivatives of strain S735 [18] and
strain 10 [23] have been described. S735 is a weakly viru-
lent isolate of serotype 2.When orf2 (locus tag SSU0135 in
P1/7 genome) from the virulent S. suis strain 10 was
expressed from plasmid pCOM1-orf2 in strain S735
(S735-pCOM1-orf2), the virulence of the strain was
increased drastically [22]. Bacterial strains were grown
overnight at 37°C and 5% CO2 on Columbia blood base
agar plates (Oxoid) containing 6% (vol/vol) horse blood
and 1 µg ml−1 of erythromycin for plasmid maintenance.
To grow the bacteria in liquid culture, one bacterial col-
ony collected from blood base agar plates was propagated
in Todd-Hewitt Broth (THB, Oxoid) supplemented with
1 µg ml−1 erythromycin and incubated overnight in 100-
ml culture bottles in the same conditions. The culture was
then diluted in THB to an optical density of 600 nm of 0.1
and incubated till exponential phase. To grow the bacteria
in host body fluids, porcine serum (VWR), and hepari-
nized fresh blood derived from 3–5 weeks old piglets
(WBVR) were used. Shortly, THB cultures at logarithmic
phase were diluted to ∼107 colony-forming units
(CFU) ml−1, inoculated in 100% normal porcine serum
or whole blood, and incubated at 37°C. Bacterial load was
monitored by CFU counting using Colombia agar plates.
Preparation of bacterial mutants
To generate strains 10 ΔSSU0288, 10 ΔSSU0682, and 10
ΔSSU1577, chromosomal DNA of S. suis strain 10 was
extracted and purified by standard methods
(ZymoResearch) and used as template in PCR reac-
tions. DNA segments flanking the genes of interest
and a spectinomycin-resistance cassette were amplified
by PCR with primers listed in supplementary Table S1.
PCR assays were performed using the High Fidelity
Polymerase kit (New England BioLabs) in
a thermocycler. PCR products were analyzed on 1%
agarose gels and purified using commercial kits
(ZymoResearch). Then, PCR products (segments of
flanking genes and spectinomycin-resistance cassette)
were used as template for a new PCR reaction using
primers flanking the extreme segments. The final PCR
product was used to transform S. suis strain 10 follow-
ing previously described procedures [24].
Transformants were selected on solid medium contain-
ing spectinomycin (100 μg ml−1), and the correct gen-
eration of knockout mutants was verified by PCR and
sequencing.
Animal experiments
All animal experiments performed in this study were
approved by the ethical committee of the institute, in
accordance with the prevailing principles and obliga-
tions of Dutch Law on animal experiments (permit
numbers 2010113c and 2013033c).
Challenge of pigs for gene expression analysis
A total of 21 cesarean-derived colostrum-deprived
(CDCD) piglets were used for transcriptomic experi-
ments. The first 3 days of life, piglets were treated
intramuscularly with enrofloxacin (Baytril®, Bayer)
according to manufacturer’s instructions to prevent
disease due to the general lack of passive immunity.
Prior to infection, blood was extracted and collected in
heparin tubes for plasma collection as well as in
PAXgene tubes (PreAnalytiX) for RNA isolation. At
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the same time, tonsils of all piglets were sampled with
swabs, and the absence of colonization by S. suis was
verified by PCR analysis [23] using specific primers for
the S. suis gdh gene [25] (supplementary Table S1). At
the age of 4 weeks, the animals were infected intrave-
nously on study day 0 with 106 CFU of S735-pCOM1-
orf2 (n = 15) or S735-pCOM1 (n = 6). After infection
all piglets were orally administered erythromycin
(40 mg kg−1 body weight) twice daily to keep selection
pressure on plasmids. Blood was collected in heparin
tubes and PAXgene tubes (Qiagen Hilden) at days 1, 2,
3, and 4 postinfection. Rectal temperatures and health
status of piglets were recorded four times a day, scoring
nonspecific (reduction in appetite and depressive beha-
vior) and specific symptoms [lameness, central nervous
system (CNS) symptoms (i.e. locomotor disorders,
opisthotonos, and nystagmus), kyphosis (arched back)
and shivering, the latter two being considered as symp-
toms of sepsis and serositis] of streptococcal disease.
When piglets showed specific symptoms of S. suis
infection, they were euthanized to minimize suffering,
otherwise they were euthanized at the end of the
experiment (6 days postinfection). During necropsy,
tissues known to be affected by S. suis infection were
examined carefully, i.e. various joints, peritoneal, and
pleural cavity, pericardia and CNS specimens were
taken to determine the presence of S. suis by CFU
counts. Tissue samples (CNS, joint capsule, heart,
lungs, and spleen) were also fixed in 4% of formalde-
hyde for histology. For pathohistological analysis, for-
malin-fixed organs were embedded in paraffin,
sectioned at 3–5 μm, and slides were stained with
hematoxylin and eosin and examined for the presence
and the degree of inflammation. “Mean survival post-
infection” was calculated by averaging the survival time
in days from inoculation until they showed specific
symptoms of S. suis infection and used as a measure
of disease severity. “Fever Index” was calculated as
a percentage of the number of observations in which
piglets had a body temperature ≥40°C divided by the
total number of observations.
Coinfection experiments
To assess the contribution of specific genes to infection,
coinfection experiments were performed. Four-week-
old piglets from a farm free of relevant swine pathogens
and without history of S. suis were used. Piglets were
confirmed to be free of S. suis infections by PCR exam-
ination of tonsil swabs. Piglets were infected intrave-
nously with 106 CFU of strain 10 and 106 CFU of an
isogenic mutant. Blood samples were collected on
a daily base to monitor for bacterial growth. As soon
as animals showed specific signs for S. suis infection as
described above, animals were euthanized and sub-
jected to necropsy as described. Organs of infected
animals were weighed, mixed with one volume of
THB medium and homogenized in a Stomacher 400
(Seward). The ratio of the mutants over wild-type bac-
teria in blood, serosa fluids, joint fluids, and homoge-
nized organs were determined by plating on Colombia
agar, either containing or not spectinomycin, and CFU
counting after overnight incubation. Data obtained
from animal experiments were analyzed with
GraphPad Prism version 7 for statistical comparisons
using unpaired t test.
Bacterial RNA isolation from standard laboratory
cultures and infected pigs
To obtain RNA from in vitro cultures, cells from cultures
growing in THB, at exponential and stationary phases,
were harvested by centrifugation (20,000 x g during 10
min), and the resultant pellet was snap-frozen in liquid
nitrogen. Triplicate RNA extractions were performed on
two independent cultures as described below.
To extract bacterial RNA from different infection
sites, bacteria in fluids of inflamed joints, pericardial
fluids from heart and from the surface of the
meninges were collected by rinsing the organs with
sterile PBS. The selected sites showed signs of inflam-
mation and massive bacteria loads and were therefore
optimal for RNA extraction. All collected fluids were
diluted 1:1 with PBS, centrifuged for 5 min at 850 x g
to remove host cells, and bacterial cells were har-
vested by centrifugation (20,000 x g 10 min). The
resulting pellets were snap-frozen in liquid nitrogen.
A total of 21 bacterial pellets isolated from 10 indi-
vidual piglets were collected (Table S2 in supplemen-
tal material). The frozen pellets were thawed on ice,
suspended in 600 µl of Trizol (Invitrogen), and bac-
teria were disrupted during 40 s in a Fastprep-24
homogenizer (MP Biomedicals). Then, 120 µl of
chloroform was added. After mixing for 15 s, the
mixture incubated for 3 min at room temperature
(RT) and then centrifuged for 15 min at 20,000 x g.
The resulting supernatant was mixed with 1 volume
of chloroform, and RNA was precipitated by adding
1 volume of isopropanol and incubation for 30 min
at RT or for 16 h at −20°C. RNA was then collected
by centrifugation, washed with 70% ethanol and sus-
pended in water. Subsequently, RNA was purified
using a Nucleospin RNA II kit (Macherey-Nagel)
according to manufacturer’s instructions. Eukaryotic
RNA was removed from in vivo samples using the
MicrobEnrich kit (Ambion).
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Reverse transcription—Quantitative PCR (RT-qPCR)
About 20–50 ng of bacterial RNA was used to gen-
erate cDNA using the Ovation PicoSl WTA system v2
(Nugen) following manufacturer’s indications, and
the resulting cDNA was purified with MinElute spin
columns (Qiagen). Fragments of selected S. suis genes
were amplified by qPCR in an ABI7500 system
(Applied Biosystems) using purified bacterial cDNA
as template. Included were cDNA preparations gen-
erated from bacterial RNA extracted from different
sites of infected animals (supplementary Table S2)
and from bacteria growing in THB medium. The
qPCR reactions were done in tryplo with primer
pairs listed in supplementary Table S1 and POWR
SYBR Green PCR Master Mix (Applied Biosystems)
according to manufacturer’s instructions. GeNorm
identified gyrA, proS, and mutS as the most stably
expressed reference genes (n = 7) for normalization of
all data using the Δ -Ct method [26]. For each PCR
reaction, a standard curve consisting of tenfold serial
dilutions of a vector containing the gene of interest or
water as negative control were incorporated. Data
analysis was performed using the ABI7500 Software
(Applied Biosystems).
Microarray analysis
cDNA preparations that were positive for S. suis orf2 by
qPCR were used for microarray experiments. cDNA
(0.5–2.5 µg) was labeled with cyanine 3-d-UTP using
the Genomic DNA Enzymatic Labeling kit (Agilent
Technologies) according to manufacturer’s instructions
and purified using Amicon Ultra-30K membrane filters
(Millipore). Prior to hybridization, pure labeled cDNA in
Agilent blocking reagent and Agilent Hi-RPM buffer was
incubated for 3 min at 95°C followed by 30 min at 37°C.
The mixture was then hybridized to one array of an 8 ×
15 k custom S. suis oligo-array (Agilent Technologies)
containing probes based on genome sequences of strain
P1/7 [27] and probes designed on incomplete genome
sequences of strains 891,591, 8067, 7917, and 6388 and
incubated at 65°C in a rotator hybridization oven. After
17 h, arrays were washed for 5 min at RT in Oligo aCGH
wash buffer 1 (Agilent Technologies) and subsequently
for 1 min at 37°C in Oligo aCGH wash buffer 2. Arrays
were dried at RT and scanned using a Surescan high-
resolution DNA microarray scanner (Agilent
Technologies), followed by data analysis using Feature
extraction software and Genespring GX software, both
also from Agilent Technologies.
Bioinformatics
Data derived from microarrays were clustered in
Genespring to determine similarity of samples using
hierarchical clustering based on the Pearson correlation
coefficient, and linkage was determined using the aver-
age neighbor’s method. KegArray software (available at
http://www.genome.jp/kegg/) was used for pathway
analysis of regulated genes, and gene ontology was
attributed from annotated predictions in publicly avail-
able S. suis genome sequences.
Results and discussion
Experimental infection of piglets with
S735-pCOM1-orf2 strain causes streptococcal
disease
S. suis strain 10 and P1/7 are clinical isolates of serotype
2 and used as reference strains for pig infection experi-
ments. Therefore, they are well suited for transcrip-
tomic studies in vivo. However, to reduce the number
of animals, we used S. suis strain S735-pCOM1-orf2
[22]. Strain S735-pCOM1-orf2 is more virulent than
strains 10 and P1/7, and it can be massively recovered
from inner organs and blood in experimental animal
infections. Thus, 15 piglets were infected intravenously
with the S. suis strain S735-pCOM1-orf2. All piglets
developed severe invasive infections within 2 days
with a mean fever index of 48% and mean survival of
51 h postinfection. Table 1 summarizes the clinical
symptoms, bacteriology, and histopathological findings
in piglets after experimental infection. S. suis was iso-
lated from CNS of 12 piglets, seven of which developed



























The numbers of affected animals and joints and the total of examined joints are indicated.
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clinical meningitis. Additionally, arthritis was apparent
in 14 piglets, pericarditis in 11 piglets, and pneumonia
in 13 piglets. Severe inflammation of serous membranes
(pleura, pericardium, and peritoneum) was observed
within 60 h postinfection (data not shown).
Bacteriological examination at different sites of infec-
tion confirmed that indeed all piglets were infected
with S. suis. The pathogen was isolated from 141 out
of 225 specific sites of infection (63%), including joints,
heart, and brain (Table 1). To verify that the induced
clinical symptoms were characteristic of S. suis infec-
tions, histopathological studies were conducted on dif-
ferent organs. Examination of cerebrum, cerebellum,
and brain revealed a fibrinpurulent meningitis in 10
out of the 15 piglets (Table 1), indicating typical acute
infection. Incidentally, encephalitis was observed. In
the synovia of 10 out of 15 piglets a fibrinopurulent
with microvascular thrombi and fibrinopurulent epi-
carditis with large influx of neutrophils was found. All
six piglets infected with the S. suis isolate S735-pCOM1
as a control survived till the end of the experiment, and
in general they showed nonspecific symptoms of strep-
tococcal infections (indicated in material and methods).
In conclusion, S. suis strain S735-pCOM1-orf2 induced
a very acute onset of streptococcal disease symptoms as
previously described [6].
Global changes in the transcriptomics during
invasive infection
Genome-wide transcription profiles of strain S735-pCOM
1-orf2 isolated from blood and from infection sites that
showed large signs of inflammation during experimental
infection [i.e. meningeal fluid (hereafter brain), joint fluid
(hereafter joint), and pericardial fluid (hereafter heart)],
and from logarithmic THB cultures were obtained as
described in section “Materials and methods.” All genes
differentially expressed in vivo from all infection sites
(average) compared to in vitro are listed in supplementary
Table S3 along with p values and fold change (FC) differ-
ences, assigned gene features and homologies. A total of
665 genes on the array, i.e. about 30% of the genome, was
differentially transcribed (p < 0.01). Genes were further
ranked based on an FC of at least two (log2 ratio ≤−2 and
≥2) and on the presence of a homologue in the publicly
available P1/7 genome sequence, resulting in 257 genes.
Selected genes were then grouped according to biological
processes, molecular functions, and cellular localization
(Figure 1). According to assigned gene ontology annota-
tions, a large number of genes that were differently regu-
lated in vivo had no known predicted function (22% of
annotated genes) or a general-function prediction (5.7% of
annotated genes) (Figure 1(a)). Some of those genes are
organized in operons. Examples are two operons, each
containing a group of genes (SSU1277-SSU1280 and
SSU1551-SSU1556) encoding predicted membrane pro-
teins of unknown function, which are strongly downregu-
lated in vivo compared to in vitro. Of the 257 differentially
regulated genes, 18% are involved in cell wall, membrane,
and envelope biogenesis, 8.1% in amino-acid metabolism
and transport, 6.9% in carbohydrate metabolism or trans-
port, and 6.9% in energy production or conversion, among
others (detailed in Figure 1(a)). In most of these functional
categories, the majority of the genes were downregulated
during infection. Exceptions are the functional categories
translation, replication and repair, and nucleotide metabo-
lism and transport, which mostly contain upregulated
genes (Figure 1(a)). For specific biosynthesis and degrada-
tion pathways of certain amino acids, fatty acids, ketone
bodies, terpenoid backbone or pyruvate metabolism,
among others, all genes were either up- or downregulated
(Figure 1(b)). In contrast, several general pathways, such as
biosynthesis of secondary metabolites, starch, and sucrose
metabolism, carbon metabolism or glycolysis and gluco-
neogenesis, included both up- and downregulated genes
(Figure 1(b)). Besides, 22 genes encoding hypothetical
transporters for sugars, metals, amino acids, and vitamins,
among others, were also regulated, of which 15 and 7 were
down- and upregulated, respectively. Many genes coding
for predicted integral membrane proteins were up- (12%)
or downregulated (21%) (Figure 1(c)). A lower number of
genes encoding secreted proteins, including lipoproteins
and surface-anchored proteins, was also identified, of
which 8% and 4% were up- and downregulated, respec-
tively (Figure 1(c)). Overall, although many genes were
constitutively expressed, these data reflect large differences
in expression of genes belonging to a variety of functional
categories when comparing S. suis grown in the host vs.
THB medium.
Niche specific expression patterns during infection
We next investigated bacterial gene expression for each
infection site compared to THB medium. Table S4 in
supplemental material lists the complete dataset of regu-
lated genes (p < 0.01) for each site of infection, including
putative or demonstrated functions, p values and FC differ-
ences. The expression profiles of the 552 selected genes
were clustered by hierarchical clustering analysis (Figure 2
(a)). Transcriptome profiles derived from organs and THB
were similar and distinct from those derived from bacteria
recovered from blood. This is in accordance with a large
number of genes differentially expressed in blood (n =
406), followed by brain (n = 261), heart (n = 222), and
joints (n = 111) compared to in vitro cultures. Remarkably,
300 genes were exclusively altered in one infection site,
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mostly in blood. Figure 2(b) details the numbers of up- and
downregulated genes within infection sites for filtered
genes (FC log2 ratio ≤−2 and ≥2). Expression of many
genes (n = 248) was altered at least in two infection sites,
and some genes (n = 38) were altered in all sites of infec-
tion. A total of 26 genes revealed no significant differences
in expression when sites of infection were compared to
each other. These data are suggestive of specific transcrip-
tome profiles associated with each infection site. In sum-
mary, our comparisons indicate that S. suis adapts gene
expression for dissemination in the host.
To validate the transcriptomics data obtained by
microarrays, the expression profiles of a subset of
representative genes were analyzed by RT-qPCR. We
selected genes with variable expression level at different
infection sites and from different functional categories,
i.e. SSU0357, SSU0899, and SSU1849. Figure S1 (sup-
plemental material) shows gene expression profiles
obtained by RT-qPCR and microarrays for each
selected gene. Except for gene SSU0899, where
transcription levels in blood and joint were upregulated
in RT-qPCR but not in microarrays, RT-qPCR analysis
confirmed our microarray data.
Involvement of regulators in the adaptation of S.
suis to the host
A total of 35 genes encoding for putative regulators
were differently expressed when bacterial transcrip-
tomes derived from infection sites were compared
with those from bacteria grown in vitro in THB (see
Figure 3(a) for examples). The number of differentially
expressed regulators varied considerably for bacteria
from blood and tissues (20 for blood, 7 for joint, 12
for heart, and 9 for brain). Thus, in the transition from
THB via blood to tissues, the expression of many reg-
ulators is first changed in blood and it is changed again
in the transition from blood to tissues, in line with the
transcription profiles (Figure 2(a)).
Figure 1. Classes of genes differently expressed in S. suis during infection vs growth in culture medium. The numbers of up- and
downregulated genes clustered according to (a) annotated COG categories and (b) metabolic pathways based on KEGG database is
given, as well as (c) the predicted localization of the corresponding gene products. Only significantly expressed genes homologous
to genes found in the P1/7 genome with at least 2 log2 FC differences and statistical significance p < 0.01 were considered. In panel
(b), categories with only one gene were not considered and classified as others.
Abbreviations: PTM: post-translational modifications; met: metabolism; bio: biosynthesis; degr: degradation.
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Many of the identified regulators have key roles in
metabolism and transport that can be also related to
pathogenesis and virulence. Among them, the global reg-
ulators CodY and CiaR that were upregulated in the
bacteria from blood and brain (Figure 3(a)). CodY con-
trols gene expression in response to amino acid availabil-
ity and stress conditions [28]. A codYmutant of an S. suis
serotype 2 strain was attenuated in a mouse infection
model and significantly inhibited in resistance to phago-
cytosis [29]. CiaR is part of the CiaHR two-component
system, which is widely distributed among streptococci
[30]. In S. suis, CiaRH system mutants showed increased
susceptibility to killing by macrophages and were also
attenuated in mice and pig models [31]. Also in a group
B Streptococcus, a ciaRmutant showed reduced survival in
neutrophils, human macrophages, and brain microvascu-
lar endothelial cells [32]. Hence, we speculate that the
S. suis regulators CodY and CiaR may promote resistance
to phagocyte clearance and antimicrobial peptides in
blood and/or meninges, which is key to survival of the
pathogen in the bloodstream, for blood-brain barrier
penetration, and for colonization of the meninges.
Figure 2. Profiles of up- and downregulated genes at different sites of infection. (a) Hierarchical clustering of the differentially
expressed genes showing the data for all indicated infection sites and for growth in liquid culture (TH broth) at stationary phase.
Clustering shows well-defined partitions for each site of infection. For all groups, upregulated (yellow) and downregulated (black)
genes are indicated as relative to THB cultures at logarithmic phase. (b) VENN diagram indicating the numbers of regulated genes at
each infection site. Genes were selected based on an FC of at least two (log2 ratio ≤−2 or ≥2) and a p < 0.01. Sites of infection were
meningeal fluid (indicated as brain), joint fluid (indicated as joint), pericardial fluid (indicated as heart) and blood.
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Figure 3. Heatmap showing variable regulation of genes participating in diverse functional categories at different sites of infection. The genes
depicted are involved in the functional categories regulators (a), protein folding (b), metabolism (c), transporters (d), and virulence factors (e).
Sites of infection are indicated at the top of each panel. The corresponding locus tag in the P1/7 genome, gene name (when appropriate), and
predicted or demonstrated pathway (panel c), substrates (panel d), and functions (panel e) are depicted. Gene names according to the
annotated P1/7 genome sequence or the literature are provided. Alternatively, nameswith one asterisk refer to regulator family type. The gene
expression levels obtained in the microarray studies are represented in a color scale (indicated at the top) according to FC in vivo vs. THB
growth cultures at logarithmic phase. Red indicates induction and blue repression. Whereas appropriated, unregulated genes are also shown.
The figure pretends to be representative rather than exhaustive; for an extensive list, see supplementary Table S4.
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Transcripts of covS, the product of which is part of
the CovRS regulatory system, were slightly downregu-
lated at several sites of infection as compared to THB
(Figure 3(a)). CovRS is a global repressor of virulence
and colonization in many pathogenic bacteria.
Together with the upregulation of codY and ciaR, this
indicates that S. suis requires different virulence factors
to survive in particular infection sites. Other differen-
tially expressed regulators play a role in responses to
stress conditions. Examples include the HrcA and
SpxA1 proteins. The hrcA gene was downregulated at
all sites of infection except brain (Figure 3(a)). HrcA is
a repressor protein that controls the expression of the
genes of DnaK and GroEL operons. These chaperones
participate in the folding of nascent proteins, refolding
of damaged or misfolded proteins, protein secretion,
and presentation of damaged proteins to degradative
pathways [33,34]. Unexpected, dnaK and groEL were
downregulated (Figure 3(b)) whilst, in contrast, the tig
gene that codes for the chaperone trigger factor was
upregulated at diverse sites of infection (Figure 3(b)).
Deletion of tig in the S. suis strain sc21 resulted in
enhanced transcript levels of hrcA in vitro experiments
[35], which could partially explain downregulation of
hrcA at certain infection sites. In any case, this suggests
that the production of some chaperones could be regu-
lated in vivo by multiple factors. In contrast to hrcA,
spxA1 was specifically upregulated in brain tissues
(Figure 3(a)). SpxA1 proteins upregulate several
S. suis genes known to be involved in oxidative stress
responses [36], such as nox, tpx, and sodA, which
encodes a NADH oxidase, a thiol peroxidase and
a superoxide dismutase, respectively. Indeed, tpx and
sodA, but not nox, were upregulated in brain tissues
(Figure 3(c)). Hence, the differential regulation of hrcA
and spxA reflects different counteracting responses of
the pathogen to environmental stresses imposed by the
host in particular infection sites. In addition, expression
of the genes for several other regulators of diverse
families, such as MarR, XRE, PadR, TetR, and GntR,
was differentially altered (Figure 3(a)); yet, their parti-
cular role during S. suis infection remains to be inves-
tigated. Overall, these data indicate that S. suis requires
a specific repertoire of regulators to adapt to the differ-
ent organs and blood during infection.
Adaptation of S. suis metabolism during infection
The expression of genes involved in metabolic path-
ways and transport systems varied for bacterial tran-
scriptomes isolated from different organs and blood, in
accordance with the variety of genes encoding for dif-
ferent regulators. Considering the rapid onset of the
disease and the variable composition of nutrients in
body sites, this indicates a rapid adaptation of the
bacterial metabolism when the pathogen gains access
to blood and disseminates to organs. The ability of
S. suis to use different carbohydrates plays an important
role in survival during infection or colonization, and it
has been related with virulence [14]. The alteration of
expression of representative genes coding for enzymes
of different metabolic pathways is illustrated in Figure 3
(c) and summarized in Table S5 (supplemental mate-
rial). Several genes of the pathway for the utilization of
maltodextrin and maltodextrin-containing polymers
were upregulated in tissues but not in blood (Figure 3
(c)). Among these genes are apuA and amy, encoding
an amylopullulanase and an α-amylase, respectively.
These enzymes cleave α-1,4 and α-1,6 glycosidic
bonds between glucose residues in starch or mamma-
lian glycogen, resulting in partially hydrolyzed struc-
tures like maltodextrins, disaccharides, and
trisaccharides. Expression of apuA has been shown to
be downregulated in culture medium in the presence of
glucose [14], which is relatively abundant in blood
(4.4–6.6 mM) compared to THB medium, and upregu-
lated in the presence of pullulan, a starch, which is
present in the intestine, oral cavity and in different
tissues (joint, brain, and heart) (0.25–0.55 mM). The
upregulation of the genes for these hydrolytic enzymes
is in accordance with the upregulation of the malC and
malD genes encoding components of a putative ABC
transporter for maltose and maltodextrins and of malT
encoding a component of a putative bifunctional PTS
transporter for glucose and maltose (Figure 3(d)).
Internal glycogen is degraded to glucose 1-phosphate
by GlgP2 and MalQ2 and synthetized from glucose1-
phosphate by GlgC, GlgA, and GlgB. The correspond-
ing genes are organized in an operon. Whilst genes
encoding proteins that participate in glycogen degrada-
tion were upregulated, genes for proteins involved in
glycogen biosynthesis were downregulated in blood,
joints, and heart but not in the brain (Figure 3(c)),
suggesting the necessity for S. suis to utilize glycogen
rather than to store it. Streptococcus spp. can also use
lactose and galactose as energy sources through the
tagatose 6-phosphate pathway, and galactose through
the Leloir pathway. In S. suis isolated from heart tissue,
genes encoding enzymes that participate in either of the
above pathways were downregulated, e.g. the galU and
galE genes of the Leloir pathway (Figure 3(c)). These
enzymes produce UDP-glucose and UDP-galactose,
respectively. Both are precursors for different virulence
factors such extracellular polysaccharides. Indeed, galU
expression was shown to be essential for capsule bio-
synthesis in S. pneumoniae [37] and upregulation of the
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Leloir pathway through the autoinducer AI2 led to
increased production of capsular polysaccharide with
a subsequent hypervirulent phenotype [38]. As the
capsule is also considered an important virulent factor
in S. suis [39–44], why would S. suis downregulate
capsule production in heart tissues? It has been
reported that 34% of S. suis isolates from cases of
porcine endocarditis lost their capsules, whilst, in con-
trast, 100% of meningitis isolates that were capsulated
[45]. Loss of capsule enhances the ability of the bacteria
to adhere to porcine cells and to generate thick bio-
films, thus facilitating endocarditis [46,47]. It is, how-
ever, important to mention that we extracted bacterial
RNA from pericardium-associated bacteria rather than
from endocardium. Thus, apparently, downregulation
of genes involved in the Leloir pathway could also be
relevant for colonization of the pericardium.
Streptococcus spp. metabolize sugars into pyruvate
and convert pyruvate into lactate or into formate and
acetyl-CoA. Acetyl CoA is the substrate in the pathway
for fatty acid biosynthesis. Interestingly, many genes
that participate in the fatty acid metabolism and bio-
synthesis pathways, some of which are organized in an
operon comprising SSU1596-SSU1609, were downregu-
lated in blood and brain (supplementary Table S5).
Fatty acids are rather abundant in serum, blood, and
brain, and it has been reported that several Gram-
positive bacteria can incorporate exogenous fatty acids
in their membranes [48,49]. On the other hand, altera-
tion of the fatty acid synthesis pathway leads to varia-
tion in the membrane composition that may contribute
to resistance to antimicrobial peptides and lytic
enzymes produced by the host [50]. It has been
shown that a cathelicidin-related antimicrobial peptide
is produced in the endothelial cells of the blood-brain
barrier and in cells of the meninges after meningococ-
cal infection of mice [51]. Thus, low requirements for
fatty acid biosynthesis could be related with resistance
to host defenses. In addition, regulation of genes
involved in the biosynthesis of amino acids was speci-
fically associated with the sites of infection, and this
was also observed for genes involved in many metabolic
routes (summarized in supplementary Table S5).
The different availability of nutrients for S. suis in
diverse body sites with the consequent activation of
a variety of metabolic pathways also resulted in the
altered expression of many genes (n = 47) that code
for (components of) putative transporters. Examples
include the malC and malD genes encoding compo-
nents of an ABC transporter of maltose and maltodex-
trins, and PotD, the substrate-binding component of an
ABC transporter of polyamines (Figure 3(d)). A total of
13 genes encoding components of 11 transporters was
exclusively altered in one infection site. The genes metQ
or bioY, which encode substrate-binding proteins for
methionine and biotin (Figure 3(d)), respectively, are
examples. Some transporters are assigned functions in
metal transport, reflecting the nutritional immunity
imposed by the host. The gene encoding FhuD, the
substrate-binding lipoprotein of an ABC transporter
involved in iron acquisition [52], was highly upregu-
lated in all infection sites, with the exception of brain
(Figure 3(d)). Sera derived from mice infected with
S. suis contained antibodies against this protein [53],
confirming that it is indeed expressed in vivo. Genes
coding for a putative cobalt transport system
(SSU0264-SSU0267) were upregulated only in joint
and heart. In contrast, genes corresponding to other
metal-transport systems were downregulated including
those for a zinc/manganese transporter (SSU1865-SSU
1867), which were downregulated in blood and brain,
and for two putative heavy metal-transporting P-type
ATPases (SSU0288 and SSU1214). The substrates of
these latter transporters may include several metal
ions, e.g. copper (SSU1214), and in most cases, they
act as efflux pumps of toxic metal ions [54]. The strong
downregulation of the genes encoding these transpor-
ters most likely reflects a lower abundance of these ions
in vivo than in vitro.
Regulation of putative and known virulence factors
Of the 26 genes encoding known or putative virulence
factors investigated, 10 were differentially regulated in
expression (Figure 3(e)). Among them, several genes
encoded for extracellular proteases. One of them,
SSU1773, which was upregulated in bacteria from
blood, joint, heart, but not in brain, as compared to
THB-grown bacteria. The function of this protein has
not been elucidated. Sequence alignments of the pre-
dicted protein revealed that it is member of the sub-
tilisin-like serine protease family. The protein contains
an N-terminal signal peptide with a YSIRKxxxGxxS
motif, required for protein secretion and processing.
The C-terminal extreme contains a LPXTG motif for
anchoring of the protein to the bacterial cell wall. The
signal peptide is followed by a peptidase S8 family
domain, which is interrupted by the insertion of a PA
domain in a loop, and an fn3_5 domain, frequently
found in Streptococcal C5a peptidases [55]. C5a pepti-
dases cleave the complement component C5a, which is
key to neutrophil activation and recruitment to the site
of infection. In addition, these proteins can function as
adhesins/invasins to epithelial and endothelial cells
[56,57]. Indeed, SSU1773 was identified as relevant for
adherence to host cells in a recent screening of TraDIS
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libraries of S. suis P1/7 in vitro organ culture system
[58]. However, the protein lacks a conserved RGD
motif usually involved in integrin binding.
Furthermore, the recombinant protein reacted with
sera of convalescent pigs [58] showing that it is pro-
duced during infection, in line with our observations.
Interestingly, immunization with this protein in com-
bination with four other antigens elicited a protective
response against S. suis in pigs after an intranasal chal-
lenge [58]. Together, these works reflect the potential
role of SSU1773 in the colonization of the upper
respiratory tract and in pathogenesis. In contrast to
SSU1773, we did not find altered expression of the
zmpC gene encoding a surface-anchored zinc metallo-
protease C in vivo. Earlier studies showed that
a recombinant ZmpC of S. suis strain 05ZYS cleaves
human IgA1 [59], and a zmpC mutant was attenuated
in a pig infection model [60]. However, this activity has
been recently disputed, as S. suis strains P1/7,
CCUG7986, CCUG7984, and CCUG42755, which con-
tain a zmpC gene, do not cleave human IgA1 [61]. In
line with this notion is that S. suis ZmpC shares struc-
tural homologies with S. pneumoniae ZmpC that lacks
IgA1 protease activity [62]. Pneumococcal ZmpC acti-
vates the matrix metalloproteinase 9 and cleaves
P-selectin glycoprotein ligand-1, mucin 16 (MUC16),
and syndecan-1 (SDC-1) ectodomains, while S. suis
ZmpC has only a modest activity on MUC16 and
SDC-1 [61]. The absence of this activity in a zmpC
mutant did not drastically affect the ability of S. suis
to colonize the upper respiratory tract of pigs [61].
Possibly, the absence of zmpC regulation in blood and
tissues observed in our study may also reflect the
absence of a crucial function during organ colonization,
sepsis, and meningitis, at least in S. suis strain S735-
pCOM1-orf2.
We detected high expression levels in tissue-
associated bacteria of the sly gene that codes for suily-
sin. Suilysin is a secreted extracellular protein belonging
to the family of cholesterol-dependent cytolysins that
form transmembrane pores on different eukaryotic
cells. Expression of sly was slightly increased in blood
as compared to THB medium (Figure 3(e)) in accor-
dance with its hemolytic capacity [63], which results in
the release of hemoglobin. Hemoglobin increases the
release of several proinflammatory mediators (IL-1β,
TNF-α, IL-6, and IL-8) by macrophages by acting in
synergy with cell-wall components of S. suis [64]. In
addition, suilysin reduces phagocytosis and killing of
S. suis independent of its cytotoxicity [65], and it
induces the formation of platelet-neutrophil complexes
that are involved in inflammation and organ failure in
some bacterial infections [66]. Expression of sly was
higher upregulated in tissue-associated bacteria than
in blood. One possible explanation for this is that
suilysin causes cytotoxicity to epithelial cells [67] result-
ing in the release of glycogen in infected organs, which
can then be enzymatically degraded by the apuA-
encoded amylopullulanase into maltodextrins to be
transported and metabolized by the pathogen.
Moreover, suilysin is toxic for the main cellular type
of the blood-brain barrier, i.e. microvascular endothe-
lial cells. This is consistent with the upregulation of sly
in meninges-associated bacteria in our study.
A subset of genes that encodes surface-exposed pro-
teins with functions in adhesion were not regulated
in vivo. For example, eno that codes for enolase.
Enolase binds plasminogen and fibrinogen [68] and it
was suggested that it helps the pathogen to cross the
blood-brain barrier and gain access to the CNS [69].
Also, by interacting with fibrinogen, enolase inhibits
phagocytosis and enhances S. suis survival in blood
[70]. Similarly, we did not find upregulation of the
fbpS gene, which also encodes fibrinogen-binding pro-
tein, in bacteria recovered from blood or host tissues.
A fbpS mutant resulted attenuated in a competitive
infection model in piglets [71]. mrp that encodes
a muramidase-release protein (MRP) with fibrinogen
binding properties was also not regulated. Like enolase,
MRP is often associated with virulence and reported as
a marker for highly virulent strains of Europe and Asia.
Albeit expression of eno, fbpS, and mrp was related to
virulence, alternative works suggest the dispensability
of some of these factors for S. suis virulence [reviewed
in 72], which may explain the lack of regulation in our
work. In contrast to these adhesins, genes that code for
several intracellular enzymes reported to be involved in
adhesion were regulated (Figure 3(e)). Some of these
enzymes were shown to be located at the bacterial sur-
face, although they lack a signal peptide required for
secretion. For instance, gap that codes for glyceralde-
hyde-3-phosphate dehydrogenase and was upregulated
at several infection sites (Figure 3(e)). This enzyme was
shown to contribute to adherence in different
Streptococcus species, including S. suis [73], and to
resistance to phagocytosis in group A and
B Streptococcus [74]. The enzyme was located at the
cell surface of Group B Streptococcus, and proposed to
be released upon cell lysis and then associated with
bacterial surface whereas exerts its function as
a adhesion. Other example is glnA that was upregulated
in heart and brain tissues. glnA encodes a glutamine
synthetase involved in the formation of glutamine from
glutamate and ammonia at the expense of ATP and this
function affects adhesion to epithelial cell lines [75].
Importantly, addition of exogenous glutamine to
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a glnA mutant restored the loss of adhesive properties
of S. suis [75], and thus, in contrast to glyceraldehyde-
3-phosphate dehydrogenase, the role of glutamine
synthetase on adhesion might be caused by an altered
glutamine metabolism. In any case, upregulation of
glnA expression in heart and brain tissues is in partial
agreement with previous results of colonization experi-
ments in mice models showing that a glnA mutant
displayed a significantly reduced number of bacteria
in heart and brain [75]. Yet, this could be explained
by glutamine requirements under these conditions
rather than putative adhesive functions. Moreover, the
gene encoding the surface antigen one (Sao) was down-
regulated in heart and brain as compared to blood and
joints (Figure 3(e)). Sao is an immunogenic protein and
a protective antigen [76], but the contribution of Sao to
S. suis virulence remains controversial [77].
Capsule is universally considered as a virulence factor
for S. suis [39–44]. It inhibits phagocytosis by neutrophils
and macrophages [39], and isogenic unencapsulated
mutants were attenuated for virulence in pig and mouse
models [43,44]. On the other hand, the absence of capsule
facilitates the interaction of S. suis with different cell types
[11,78]. Hence, it has been suggested that capsule synthesis
must be regulated to facilitate tissue colonization and inter-
bacterial interactions during the colonization and invasion
process. Of all genes encoding proteins for capsule bio-
synthesis (cps2E-N) and polymerization (cps2I), only cps2H
was upregulated in transcriptomes derived from blood as
compared to growth in THB (Figure 3(d)). cps2H encodes
a glycosyl transferase that participates in the formation of
the repeat unit by linking galactose to rhamnose. However,
upregulation of only one enzyme does not necessarily yield
higher capsule production, but this is possible if this
enzyme catalyze the rate-limiting step. Alternatively, the
thickness of the capsule can be regulated by
a phosphoregulatory system encoded by cps2A, cps2B,
cps2C, and cps2D. In S. pneumoniae, CpsC and CpsD
constitute the integral membrane activation domain and
the cytoplasmic kinase domain of an autophosphorylating
tyrosine kinase. CpsB (encoded by wzh or cps2D in S. suis)
is a manganese-dependent phosphatase capable of depho-
sphorylating phosphorylated CpsC [79]. In our study,
cps2D was upregulated when S. suis infected blood, brain,
and heart tissues (Figure 3(a)). Deletion of cps2B in
S. pneumoniae resulted in increased phosphorylation of
CpsD, but the resulting capsule phenotype varied [79,80].
A recent study in S. pneumoniae strain D39 described that
CpsB is essential for parental levels of capsule production
during growth under reduced-oxygen conditions, such as
met during infection, but not under high-oxygen condi-
tions, such as in the nasopharynx [81]. This activity was
independent of its phosphatase activity, suggesting that
CpsB participates in alternative capsule regulatory systems.
Anyhow, whether the increased cps2D expression levels
(cps2B in S. pneumoniae), found during S. suis infection
in our study affects capsule production remains to be
evaluated. Overall, the expression of virulence factors was
highly variable at different infection sites and this may be
related to different host defense mechanisms or acquisition
of nutrients.
Identification of genes that contribute to survival of
S. suis during infection
We next hypothesized that genes with a differential
expression during infection of pigs might contribute to
the survival of S. suis within the host. We selected two
genes coding for proteins belonging to different func-
tional categories, one encoding the substrate-binding
component of a methionine transporter (SSU1577,
metQ) and the other encoding an NADH oxidase
(SSU0682, nox). These genes were up- and downregulated
in one infection site as compared to THB growth (Figure
3(c,d)), respectively. Additionally, we included SSU0288,
the highest downregulated gene at all sites of infection as
compared to THB growth (Figure 3(d)). To understand
the contribution of these proteins to infection, we gener-
ated deletion mutants of the three selected genes in strain
10. Strain 10 is the reference virulent strain for S. suis
serotype 2 and our model strain for coinfection experi-
ments [71]. We opted to use coinfection experiments
since such experiments allow comparing the growth of
the wild type and a coinoculated isogenic mutant deriva-
tive within the same animal [71]. Since the wild type is
included as an internal control, interindividual variations
are drastically reduced, providing a precise and sensitive
method of establishing the fitness of a mutant.
Coinfections were performed intravenously, and the
CFU number of each strain was determined at multiple
infection sites to monitor bacterial dissemination.
S. suis strains 10 ΔSSU0682 and 10 ΔSSU1577 were
attenuated for growth in the blood of infected pigs, as
evidenced by a reduction in CFU of streptomycin-
resistant mutants compared to those of the wild type in
blood samples recovered 1 and 2 days postinfection
(Figure 4(a)). In contrast, mutant 10 ΔSSU0288 was iso-
lated from blood in similar amounts as the wild type after
1 day, but showed a higher survival than the wild type
after 2 days. Remarkably, the interindividual variation of
bacteria isolated of the ΔSSU0288 mutant from blood was
lower than of the wild type. Compared to the parent, 10
ΔSSU0682 and 10 ΔSSU1577 were hardly isolated from
organs (Figure 4(b)), while 10 ΔSSU0288 was isolated in
similar amounts as the wild type (Figure 4(b)). To con-
firm that the attenuation of the ΔSSU0682 and ΔSSU1577
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mutants for growth in blood, all mutants were first incu-
bated in porcine serum in vitro; under these conditions,
erythrocytes and leukocytes are absent. Bacteria were
recovered at various time points to assess the number of
live bacteria. As expected, the mutants ΔSSU0682 and
ΔSSU1577 revealed an altered growth in porcine serum
compared to the parent (Figure 5(a)). The mutant
ΔSSU0682 had a similar growth rate as the wild type,
but rapidly lyses at the end of the log phase. In contrast,
the mutant ΔSSU1577 had an extended lag phase, but
once in the log phase, the growth rate does not seem to be
much different from the wild type. Then, strains 10
ΔSSU0682 and 10 ΔSSU1577 were grown in fresh porcine
blood. In contrast to serum, the results revealed a severe
attenuation of both mutants as compared to the parent
(Figure 5(b)), possibly as consequence of the activity of
host cells (e.g. bacterial killing by leukocytes). Together,
these data confirmed that the production of MetQ and
NADH oxidase is relevant for bacteremia and, thus, for
dissemination to the organs, while reduction in the pro-
duction of the putative exporter encoded by SSU0288 is
apparently important to adapt to stress conditions. To the
best of our knowledge, the role of this exporter during the
infection has not been studied before. MetQ is a surface-
exposed lipoprotein and part of an ABC transporter
involved in the acquisition of methionine in
S. pneumoniae [82]. The MetQ protein of S. suis shares
>70% of sequence identity with the S. pneumoniae homo-
logues. The growth of a metQ mutant of S. pneumoniae
was also impaired in blood, but, in contrast to S. suis, the
mutant was not attenuated for systemic infection, with
exception of reduced bacterial loads in spleen [82].
Besides, mixed infection models showed no evidence of
attenuation of the mutant in the colonization of the
nasopharynx [82]. Apparently, the role of MetQ in infec-
tion is different between both species. Several works
Figure 4. Bacterial load in organs after intravenous infection of pigs with wild-type and mutant strains. (a) Bacterial loads of wild
type and mutant derivatives in blood 1 and 2 days postinfection (dpi). (b) Bacterial loads in different organs at four dpi is shown.
Each symbol represents one individual animal and geometric means are indicated by horizontal lines for wild type (continuous) or
mutants (discontinuous). Before statistical analysis, data were log10 converted and unpaired t-test was used for statistical
comparison. Statistically significant differences were analyzed with GraphPad Prism 6 and marked at a p of < 0.05 (one asterisk)
or p < 0.001 (two asterisks).
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support a relevant role of NADH oxidase during infec-
tion. A nox mutant of S. suis exhibited impaired growth
under oxidative stress conditions [83]. When the mutant
was created in the Chinese S. suis serotype 2 strain SC19,
virulence was attenuated in mouse and pig models [84],
in line with our data in strain 10. In S. pneumoniae,
NADH oxidase was detected in cell-wall fractions suggest-
ing that the protein might also be cell surface-exposed,
although it lacks a signal sequence for secretion. Deletion
of nox in S. pneumoniae reduced significantly the adhe-
sion to epithelial cells and the mutant was attenuated in
virulence and colonization in diverse mice models [84,85].
Interestingly, mice immunized with recombinant NADH
oxidase survived a lethal challenge with S. pneumoniae
[83]. The NADH oxidase reduces free oxygen to H2O2 or
H2O through electron transfer from NADH resulting in
the production of NAD+. During glycolysis, bacteria pro-
duce NADH from NAD+. This enzyme balances the
NAD+/NADH ratio and thus glycolysis can proceed.
NADH oxidase is important coping oxidative stress con-
ditions generated by innate immune responses, i.e. reac-
tive oxygen species produced by host phagocytes, to evade
the host immune system, in agreement with our whole
blood assays. Yet, why nox expression is downregulated in
pericardia remains to be elucidated. Together with pre-
vious findings, this study shows that both proteins, MetQ
and NADH oxidase, are relevant factors for S. suis infec-
tion and that they are, therefore, attractive candidates for
the design of vaccines, e.g. live attenuated vaccines.
Concluding remarks
Analysis of the bacterial transcriptome during infection
provided valuable insights into the adaptation of S. suis to
infection of the porcine host. Specific gene expression
profiles were identified in brain, joint, and heart tissues or
Figure 5. Growth of S. suis strain 10 and mutant derivatives in (a) porcine serum and (b) porcine whole blood. Bacterial strains were
grown in THB medium, diluted, and then incubated in porcine serum or fresh porcine blood. The numbers of live bacteria were
determined by CFU counting at different time points as indicated. Experiments were repeated at least three times. For both panels,
the left graft shows the growth of one representative experiment with three technical replicates. The right graft shows the area
under the curve (AUC) relative to the wild-type strain, arbitrarily set to 1, of at least three biological replicates with average and
standard deviation. Statistically significant differences were analyzed with GraphPad Prism 6 (unpaired statistical t-test) and are
indicated with one asterisk (p < 0.05) or two asterisks (p < 0.01).
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blood. Although many of the differentially expressed genes
encode proteins previously proposed to be relevant for
infection of the host, many others were identified here for
the first time including regulators, potential transporters,
and integral membrane and secreted proteins without
assigned functions. It will be important to investigate the
role of these novel structures in future works. Our work
highlights that the pathogen undergoes a rapid adaptive
response that remodels bacterial metabolism and virulence
(Figure 3(b–e)), probably governed in part by a repertoire
of differentially expressed transcriptional regulators
(Figure 3(a)). Clearly, different structures are differently
required at specific niches in the process of dissemination
and expansion of the disease. We also show that NADH
oxidase andMetQ play a relevant role in the survival of the
pathogen in blood (Figures 4 and 5), a prerequisite for
colonization of organs. In contrast, downregulation of the
putative ion exporter encoded by SSU0288 is beneficial for
the adaptation of S. suis to blood (Figures 4 and 5).
This study focused on transcriptomic profiles of bacteria
isolated from blood and tissue-associated bacteria during
infection. Future studies focused on transcriptomic profiles
of different niche locations within organs or during adhe-
sion and invasion, a prerequisite for streptococcal infection,
or following the dynamics of infection, will complete the
gene expression profiles of this pathogen during host
interaction.
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